Critical appraisal of lurasidone in the management of schizophrenia
Silvio Caccia, Luca Pasina, Alessandro NobiliIstituto di Ricerche Farmacologiche, “Mario Negri”, Milan, ItalyAbstract: Lurasidone is a new atypical antipsychotic in the benzoisothiazoles class of chemicals. Like most second-generation antipsychotics it is a full antagonis...
Enregistré dans:
Auteurs principaux: | Caccia S, Pasina L, Nobili A |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/96d715a4b74646e18bf4a8fb4ce307f5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The clinical utility of lurasidone in schizophrenia: patient considerations
par: Harvey PD
Publié: (2015) -
Lurasidone as a potential therapy for bipolar disorder
par: Woo YS, et autres
Publié: (2013) -
Lurasidone for the treatment of bipolar depression: an evidence-based review
par: Franklin R, et autres
Publié: (2015) -
New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children
par: Diana Domnitei, et autres
Publié: (2010) -
Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis
par: Warnke C, et autres
Publié: (2011)